Guardant Health, Inc.
US ˙ NasdaqGS ˙ US40131M1099

SecurityGH / Guardant Health, Inc.
InsiderKrognes Steve E.
This page shows the track record and history of Krognes Steve E. insider trades in Guardant Health, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Krognes Steve E. in GH / Guardant Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GH / Guardant Health, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Krognes Steve E. in GH / Guardant Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2026-06-04 9,294 132.5072 9,294 132.5072 1,231,522 1 125.6100 -64,102 -5.21

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GH / Guardant Health, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-06-05 2026-06-04 4 Krognes Steve E. GH Common Stock S - Sale D 132.5072 -9,294 -1,232 10,222
2026-06-01 2026-05-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 19,516
2026-05-01 2026-04-30 4 Krognes Steve E. GH Common Stock M - Exercise D 154 19,362
2026-04-01 2026-03-31 4 Krognes Steve E. GH Common Stock M - Exercise D 155 19,208
2026-03-02 2026-02-28 4 Krognes Steve E. GH Common Stock M - Exercise D 154 19,053
2026-02-02 2026-01-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 18,899
2026-01-05 2025-12-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 18,745
2025-12-01 2025-11-30 4 Krognes Steve E. GH Common Stock M - Exercise D 155 18,591
2025-11-03 2025-10-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 18,436
2025-10-02 2025-09-30 4 Krognes Steve E. GH Common Stock M - Exercise D 154 18,282
2025-09-03 2025-08-31 4 Krognes Steve E. GH Common Stock M - Exercise D 155 18,128
2025-08-04 2025-07-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 17,973
2025-07-02 2025-06-30 4 Krognes Steve E. GH Common Stock M - Exercise D 154 17,819
2025-06-16 2025-06-12 4 Krognes Steve E. GH Common Stock M - Exercise D 6,674 17,665
2025-06-02 2025-05-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 10,991
2025-05-01 2025-04-30 4 Krognes Steve E. GH Common Stock M - Exercise D 155 10,837
2025-04-02 2025-03-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 10,682
2025-03-04 2025-02-28 4 Krognes Steve E. GH Common Stock M - Exercise D 154 10,528
2025-02-04 2025-01-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 10,374
2025-01-02 2024-12-31 4 Krognes Steve E. GH Common Stock M - Exercise D 155 10,220
2024-12-02 2024-11-30 4 Krognes Steve E. GH Common Stock M - Exercise D 154 10,065
2024-11-04 2024-10-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 9,911
2024-10-01 2024-09-30 4 Krognes Steve E. GH Common Stock M - Exercise D 154 9,757
2024-09-03 2024-08-31 4 Krognes Steve E. GH Common Stock M - Exercise D 155 9,603
2024-08-01 2024-07-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 9,448
2024-07-02 2024-06-30 4 Krognes Steve E. GH Common Stock M - Exercise D 154 9,294
2024-06-13 2024-06-12 4 Krognes Steve E. GH Common Stock M - Exercise D 5,592 9,140
2024-06-03 2024-05-31 4 Krognes Steve E. GH Common Stock M - Exercise D 155 3,548
2024-05-02 2024-04-30 4 Krognes Steve E. GH Common Stock M - Exercise D 154 3,393
2024-04-01 2024-03-31 4 Krognes Steve E. GH Common Stock M - Exercise D 154 3,239
2024-03-01 2024-02-29 4 Krognes Steve E. GH Common Stock M - Exercise D 154 3,085
2024-02-01 2024-01-31 4 Krognes Steve E. GH Common Stock M - Exercise D 155 2,931
2024-01-02 2023-12-31 4 Krognes Steve E. GH COMMON STOCK M - Exercise D 154 2,776
2023-12-04 2023-11-30 4 Krognes Steve E. GH COMMON STOCK M - Exercise D 154 2,622
2023-11-01 2023-10-31 4 Krognes Steve E. GH COMMON STOCK M - Exercise D 154 2,468
2023-10-02 2023-09-30 4 Krognes Steve E. GH COMMON STOCK M - Exercise D 155 2,314
2023-09-05 2023-08-31 4 Krognes Steve E. GH COMMON STOCK M - Exercise D 154 2,159
2023-08-01 2023-07-31 4 Krognes Steve E. GH COMMON STOCK M - Exercise D 154 2,005
2023-07-05 2023-06-30 4 Krognes Steve E. GH COMMON STOCK M - Exercise D 1,851 1,851
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)